Sensei Biotherapeutics, Inc. ( SNSE) - Stock Earnings
Stock symbol SNSE is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker SNSE was renamed to
FTH
effective 2026-06-16.
SNSE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.6 million USD | -4.9 million USD |
| 2025Q4 | -4.7 million USD | — USD |
| 2026Q1 | -170.2 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SNSE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -34.1 million USD | — USD |
| 2024 | -30.2 million USD | — USD |
| 2025 | -21.1 million USD | — USD |
| 2026 Est. | — | — |
SNSE
Price: $13.85
52 week price:
Earnings Per Share: -16.72 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18884
Market Capitalization: 19.7 million